# Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.

> **NCT07301658** · NA · COMPLETED · sponsor: **i+Med S.Coop.** · enrollment: 42 (actual)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **OTHER:** Novel dermocosmetic product containing cannabidiol (CBD) and Annona cherimola fruit extract.

## Key facts

- **NCT ID:** NCT07301658
- **Lead sponsor:** i+Med S.Coop.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2023-06-06
- **Final completion:** 2024-08-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301658, "Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07301658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*